San Diego. Monday 27 March 2001.
Something strange happened during a meeting with a biomedical firm our Euro-America Fund has been courting. Two dentists barged in, a tall woman and a short man, both in black lab coats, demanding to see the CTO’s molars. Grimacing, he obliged.